{"id":1060,"date":"2026-07-17T05:38:36","date_gmt":"2026-07-17T02:38:36","guid":{"rendered":"https:\/\/www.pharma-navigation.com\/?p=1060"},"modified":"2026-07-17T05:49:47","modified_gmt":"2026-07-17T02:49:47","slug":"ukrayina-2026-praktychni-vyklyky-dlya-importu-kosmetyky-ta-rol-vidpovidalnoyi-osoby","status":"publish","type":"post","link":"https:\/\/www.pharma-navigation.com\/en\/ukrayina-2026-praktychni-vyklyky-dlya-importu-kosmetyky-ta-rol-vidpovidalnoyi-osoby\/","title":{"rendered":"Ukraine 2026: Practical Challenges for Cosmetic Imports and the Role of the Responsible Person"},"content":{"rendered":"<p><em>This article was prepared following a Cosmetica Italia Servizi webinar dedicated to the new regulatory framework for cosmetic products in Ukraine.<\/em><\/p>\n<p><strong>On 30 June 2026, the Pharma Navigation team joined approximately one hundred other participants at the Cosmetica Italia Servizi webinar, \u201cExporting to Ukraine: Is Your Company Ready for the New Rules?\u201d<\/strong><\/p>\n<p>The event was organised for Italian manufacturers, cosmetic brand owners, exporters, and companies already operating in or planning to enter the Ukrainian market. The main focus was the full application of Ukraine\u2019s new cosmetic products regulatory framework from 3 August 2026 and the practical role of the Responsible Person in Ukraine.<\/p>\n<p>For Pharma Navigation, participation in this type of international professional discussion has significant practical value. European manufacturers need not only to understand Ukrainian legal requirements but also to establish an effective working model with their Responsible Person and importers. This includes defining procedures for transferring documentation, protecting confidential formulations, adapting the Product Information File, completing product notifications, and updating information after a product has been placed on the market.<\/p>\n<p>These matters form part of Pharma Navigation\u2019s daily work supporting foreign manufacturers and Ukrainian distributors.<\/p>\n<h2>3 August 2026: A Change in the Regulatory Model, Not Merely Another Deadline<\/h2>\n<p>The Technical Regulation on Cosmetic Products, approved by Resolution No. 65 of the Cabinet of Ministers of Ukraine dated 20 January 2021, entered into force on 3 August 2024. A transitional period was introduced to allow the market to adapt. Once this period ends, imported cosmetic products must be prepared in accordance with the new regulatory model.<\/p>\n<p>This model includes:<br>\n\u2022\tverification of product formulations against Ukrainian requirements;<br>\n\u2022\tappointment of a Responsible Person;<br>\n\u2022\tavailability of a compliant PIF and CPSR;<br>\n\u2022\tevidence of compliance with Good Manufacturing Practice;<br>\n\u2022\tadaptation of product labelling;<br>\n\u2022\tnotification before the product is placed on the market;<br>\n\u2022\tongoing management of complaints, undesirable effects, and product changes.<\/p>\n<p>The Ukrainian Technical Regulation is based on Regulation (EC) No 1223\/2009. However, a product that is lawfully marketed in Italy or another EU Member State does not automatically become ready to be placed on the Ukrainian market.<\/p>\n<p><strong>EU compliance provides a strong foundation, but it does not replace the Ukrainian regulatory procedure.<\/strong><\/p>\n<p>For the Ukrainian market, a product requires a locally established Responsible Person, national notification, documentation accessible to the Ukrainian authorities, adapted labelling, and clearly documented contractual arrangements between the manufacturer, importer, and Responsible Person.<\/p>\n<h2>The Most Challenging Issues for European Manufacturers<\/h2>\n<p>The large number of questions raised during the webinar demonstrated that the main difficulties concern not the general principles of European cosmetic regulation, but their practical application in Ukraine.<\/p>\n<p>Participants were particularly interested in the following issues:<\/p>\n<ul>\n<li>how the transitional arrangements will apply to future shipments;<\/li>\n<li>who should act as the Responsible Person when several importers are involved;<\/li>\n<li>where the PIF must be kept and which parts must be translated into Ukrainian;<\/li>\n<li>whether providing only the CPSR is sufficient;<\/li>\n<li>how to protect the quantitative formulation and other confidential documentation;<\/li>\n<li>who may sign or validate the safety assessment for the Ukrainian market;<\/li>\n<li>how different SKUs, shades, and packaging variants should be notified;<\/li>\n<li>when Ukrainian labelling must be applied, how the Responsible Person function may be transferred to another entity.<\/li>\n<\/ul>\n<p>These questions confirm that the principal challenge is not merely the completion of an electronic notification form. Companies must restructure the way they manage documentation, regulatory responsibilities, and the exchange of information.<\/p>\n<p>We hope that professional educational events of this kind will improve regulatory awareness among European manufacturers and suppliers. Better awareness should facilitate the exchange of information and technical documentation with Ukrainian Responsible Persons, shorten product preparation timelines, and reduce the risk of disruptions to cosmetic product supplies in Ukraine.<\/p>\n<h2>Transitional provisions: The Specific Batch Matters, Not the Brand\u2019s Market History<\/h2>\n<p>One of the most important practical clarifications concerned the application of the transitional provisions to products already present on the Ukrainian market before 3 August 2026.<\/p>\n<p>The fact that a brand or product was sold in Ukraine before this date should not be interpreted as an automatic authorisation to continue importing new batches under the previous rules. A distinction must be made between batches placed on the market before the cut-off date and subsequent shipments of the same product.<\/p>\n<p>The manufacturing date alone does not prove that a product was placed on the Ukrainian market.\nTo rely on the transitional provisions, companies should retain customs declarations, invoices, delivery notes, warehouse records, batch numbers, and other documents confirming the date and quantity of the specific products placed on the market.<\/p>\n<h2>Pharma Navigation\u2019s Practical Recommendation<\/h2>\n<p>For remaining stock placed on the market before 3 August 2026, companies should create a separate batch-specific evidence file.<br><br>\nThis file should make it possible to clearly establish:<br>\n\u2022\tthe identity of the product;<br>\n\u2022\tthe batch number;<br>\n\u2022\tthe date on which the product entered the Ukrainian market;<br>\n\u2022\tthe relevant quantity;<br>\n\u2022\tthe supporting documents on which the application of the transitional arrangements is based.<\/p>\n<p>Such a file provides much stronger evidence than a general statement that the brand has been present in Ukraine for many years.<\/p>\n<h2>The Responsible Person as the Centre of the Compliance System<\/h2>\n<p>Every cosmetic product placed on the Ukrainian market must be linked to a Responsible Person established in Ukraine. <br>\nOne Responsible Person may manage numerous products, product lines, and brands. However, the Responsible Person\u2019s role must be clearly defined for each product.<\/p>\n<p>The Responsible Person:<br>\n\u2022\tverifies the formulation, labelling, and product claims;<br>\n\u2022\tensures the availability of the CPSR and PIF;<br>\n\u2022\tverifies GMP documentation;<br>\n\u2022\tcompletes the product notification;<br>\n\u2022\tcommunicates with market surveillance authorities;<br>\n\u2022\thandles complaints;<br>\n\u2022\tcoordinates corrective actions.<\/p>\n<p>The appointment of a Responsible Person is therefore not merely nominal representation or technical access to the notification portal. It involves the transfer and performance of substantive regulatory functions and responsibilities.<\/p>\n<h2>Can a Distributor Act as the Responsible Person?<\/h2>\n<p>In the case of imported cosmetic products, the importer will generally assume the role of the Responsible Person unless this role has been transferred to another entity established in Ukraine that has formally accepted the relevant functions and responsibilities.\nThe practical question is therefore not simply whether a distributor may act as the Responsible Person, but whether this model is optimal for the manufacturer and the entire supply chain.<\/p>\n<p>A PIF may contain:<br>\n\u2022\tthe full quantitative formulation;<br>\n\u2022\traw material specifications;<br>\n\u2022\tinformation about suppliers and manufacturing processes;<br>\n\u2022\timpurity data;<br>\n\u2022\ttest results;<br>\n\u2022\tother commercially sensitive information.<\/p>\n<p>Providing the complete dossier to a distributor may create confidentiality risks and make the manufacturer dependent on a single distribution channel.<\/p>\n<p>This issue is particularly important for brands that work with several importers, plan to change distributors, or do not wish to disclose their complete formulations to every commercial partner.<\/p>\n<p>Where several importers are involved, it may be advisable to appoint one Responsible Person to centrally manage the PIF, notifications, updates, and communication with the authorities.<\/p>\n<h2>An Independent Responsible Person as an Alternative to the Distributor Model<\/h2>\n<p>Appointing an independent specialised company allows regulatory functions to be separated from commercial distribution activities.<\/p>\n<p>Under this model, the manufacturer provides the documentation to the independent Responsible Person, while distributors do not automatically receive access to the complete PIF.<br><br>\nA single documentation and notification system may be used when working with several importers. A change of commercial partner therefore does not require the entire regulatory function to be transferred.<\/p>\n<p><strong>Pharma<\/strong><strong> Navigation<\/strong><strong> provides independent Responsible Person services in Ukraine.<\/strong> <br><br>The relationship is formalised through:<br>\n\u2022\ta Responsible Person Appointment Agreement;<br>\n\u2022\ta Technical Agreement;<br>\n\u2022\ta Non-Disclosure Agreement.<br>\nThese documents define the allocation of responsibilities, documentation exchange procedures, confidentiality requirements, and the parties\u2019 interaction after the products have been placed on the market.<\/p>\n<h2>The PIF Must Be Accessible in Ukraine<\/h2>\n<p>A European manufacturer may already have a complete PIF maintained in Italy or another EU country. However, this is insufficient if the Ukrainian Responsible Person does not have actual access to the documentation and cannot provide it promptly to the market surveillance authority.<\/p>\n<p>The PIF must:<br>\n\u2022\tremain under the control of the Responsible Person;<br>\n\u2022\tbe physically or electronically accessible in Ukraine;<br>\n\u2022\tbe kept up to date;<br>\n\u2022\tbe made available to the competent authorities upon a substantiated request.<\/p>\n<p>A model under which the Responsible Person receives the dossier from the manufacturer only after an inspection has started does not reflect the substance of the Responsible Person\u2019s responsibilities.<\/p>\n<p>The CPSR does not replace the complete PIF.<br><br>\nPart B of the safety report cannot be considered separately from Part A, the formulation, raw material characteristics, impurity data, microbiological quality, stability, packaging, exposure assessment, and product labelling.<\/p>\n<p>Where a contract manufacturer does not provide a complete PIF, the brand owner may provide the underlying technical documentation from which a dossier can be prepared or adapted for the Ukrainian market.<\/p>\n<h2>Does the Entire PIF Have to Be Translated into Ukrainian?<\/h2>\n<p>The language requirement was one of the most widely discussed issues during the event.<\/p>\n<p>The organisers\u2019 written responses suggested a more practical approach than the mechanical translation of every page of the dossier.<br><br>\nDepending on the product, part of the original documentation may remain in English, while key sections, safety-related documents, and technical summaries are prepared in Ukrainian.<\/p>\n<p>The principal objective is not a word-for-word translation of the archive, but the regulatory adaptation of the PIF.<br><br>\nThis process includes:<br>\n\u2022\tanalysing the European dossier;<br>\n\u2022\tidentifying documentation gaps;<br>\n\u2022\tverifying compliance with Ukrainian requirements;<br>\n\u2022\tpreparing local documents;<br>\n\u2022\tensuring consistency between the PIF, CPSR, labelling, and notification data.<\/p>\n<h2>CPSR and the Qualifications of the Safety Assessor<\/h2>\n<p>The Cosmetic Product Safety Report is a mandatory part of the PIF.<\/p>\n<p>The key criterion for a safety assessor is the possession of appropriate qualifications and compliance with the requirements of Ukrainian legislation.<\/p>\n<p>Even where a European CPSR has been properly prepared for the EU market, it is necessary to verify whether:<br>\n\u2022\tthe underlying data are sufficient;<br>\n\u2022\tthe assessment complies with Ukrainian requirements;<br>\n\u2022\tthe conclusions can be properly substantiated before the Ukrainian authorities.<\/p>\n<p>The most reliable approaches remain:<br>\n\u2022\tpreparation of the CPSR by a qualified safety assessor who meets Ukrainian requirements; <br>\n\u2022\tappropriate review and validation of the European report for use in Ukraine.<\/p>\n<p>The assessment should not be reduced to the formal signing of an existing document.<br>\nThe assessor must review the underlying data, exposure calculations, toxicological profiles of the ingredients, microbiological quality, stability, packaging, labelling, and intended conditions of use.<\/p>\n<h2>Ukrainian Notification Is Not a Copy of the CPNP Submission<\/h2>\n<p>Ukraine\u2019s electronic cosmetic product notification system was launched on 1 December 2025.<br>\nThe notification must be submitted by the Responsible Person or its authorised employees.<\/p>\n<p>The following information is entered into the system:<br>\n\u2022\tproduct identification details;<br>\n\u2022\tproduct category;<br>\n\u2022\tproduct name;<br>\n\u2022\tcountry of origin;<br>\n\u2022\tshades and variants;<br>\n\u2022\ta graphic file of the product labelling;<br>\n\u2022\tformulation information;<br>\n\u2022\tinformation on CMR substances;<br>\n\u2022\tinformation on nanomaterials;<br>\n\u2022\tother specific product characteristics.<\/p>\n<p>During the webinar, the speakers emphasised that access to the portal is linked to personal electronic identification. A formulation cannot simply be attached as a PDF, and bulk upload functionality does not eliminate the need to verify critical information for each individual product.<br><br>\nMaterial changes to previously notified information must also be reflected in the system.<\/p>\n<p>According to an estimate presented during the webinar, the actual time required to complete a Ukrainian notification may be 10 to 20 times greater than the time typically required for a CPNP submission.<br><br>\nFor portfolios containing hundreds of products, shades, and variants, notification becomes a separate regulatory project. It requires advance preparation of the data and verification of formulations, labelling files, and commercial configurations.<\/p>\n<h2>Product, Formula, Shade, or SKU?<\/h2>\n<p>A prudent practical approach is to assess each product in its specific commercial configuration.<\/p>\n<p>Differences in any of the following may require the creation of a separate variant, an update to an existing notification, or a new notification:<br>\n\u2022\tformulation;<br>\n\u2022\tshade;<br>\n\u2022\tfragrance;<br>\n\u2022\tfunction;<br>\n\u2022\tproduct name;<br>\n\u2022\tbarcode;<br>\n\u2022\tpackaging;<br>\n\u2022\tlabelling;<br>\n\u2022\tproduct claims.<br><br>\nNot every design change automatically creates a new product.<\/p>\n<p>However, changes affecting the product\u2019s identification or the information entered in the notification system must be assessed separately by the Responsible Person.<br><br>\nThis issue is particularly relevant to decorative cosmetics, hair dyes, fragrances, and product lines with numerous variants.<\/p>\n<h2>Labelling: Translating the European Label Is Not Enough<\/h2>\n<p>Ukrainian product labelling must simultaneously comply with:<br>\n\u2022\tthe Technical Regulation on Cosmetic Products;<br>\n\u2022\tUkrainian language legislation;<br>\n\u2022\tconsumer protection requirements;<br>\n\u2022\trequirements concerning the accuracy and substantiation of product claims;<br>\n\u2022\tany specific requirements applicable to the relevant product category.<\/p>\n<p>Mandatory consumer information must be available in Ukrainian.\nAt the same time, INCI names should not be translated as ordinary text because they form part of an international nomenclature. Arbitrary transliteration may distort the information.<\/p>\n<p>A Ukrainian-language sticker may be used provided that it:<br>\n\u2022\tcontains accurate information;<br>\n\u2022\tis legible and durable;<br>\n\u2022\tdoes not obscure other mandatory information;<br>\n\u2022\tis applied before the product is made available to the consumer.<\/p>\n<p>However, relabelling after importation may create risks during customs clearance or regulatory inspections.\nThe stage at which the Ukrainian sticker is applied should therefore be determined before the products are shipped.<\/p>\n<h2>What Ukrainian Distributors Should Do Before Future Shipments<\/h2>\n<p>A general recommendation to \u201caudit the product portfolio\u201d is no longer sufficient.\nFor shipments made after 3 August 2026, distributors should implement an internal regulatory release mechanism before products are approved for dispatch.<\/p>\n<p>An order or shipment of a new batch should not receive final approval until:<br>\n\u2022\tthe Responsible Person has been appointed;<br>\n\u2022\tcontractual arrangements and confidentiality obligations have been established;<br>\n\u2022\ta sufficient documentation package has been obtained;<br>\n\u2022\tthe PIF and CPSR have been adapted;<br>\n\u2022\tthe formulation has been reviewed;<br>\n\u2022\tthe Ukrainian labelling has been approved;<br>\n\u2022\tthe notification has been completed.<\/p>\n<p>The parties should also define in advance:<br>\n\u2022\thow documentation will be updated;<br>\n\u2022\thow product changes will be reported;<br>\n\u2022\thow complaints will be transferred;<br>\n\u2022\thow the manufacturer, importer, <br> Responsible Person will cooperate after the product has been placed on the market.<\/p>\n<p>This reduces the risk of a situation in which products have already been manufactured, paid for, or shipped, but cannot be properly notified because the PIF is incomplete, the formulation is unavailable, the CPSR is unacceptable, or the labelling has not been approved.<\/p>\n<h2>Conclusion<\/h2>\n<p>The Cosmetica Italia Servizi webinar demonstrated that Ukraine\u2019s cosmetic products regulatory reform affects not only local importers, but also the regulatory, contractual, and commercial processes of European manufacturers.<\/p>\n<p>After 3 August 2026, an EU notification, a European PIF, or a brand\u2019s long-standing sales history in Ukraine will no longer be sufficient on its own.<\/p>\n<p>For each cosmetic product, companies must ensure:<br>\n\u2022\tthe appointment of a clearly identified Responsible Person;<br>\n\u2022\tthe availability of accessible and properly adapted documentation;<br>\n\u2022\tan appropriate safety assessment;<br>\n\u2022\tcompliant Ukrainian labelling;<br>\n\u2022\tcompletion of the national notification;<br>\n\u2022\tan ongoing system of regulatory support and product compliance maintenance.<\/p>\n<p><strong>Pharma<\/strong><strong> Navigation<\/strong><strong> treats notification not as an isolated administrative action, but as the final stage of a comprehensive product market-readiness process.<\/strong><\/p>\n<p>The company provides independent Responsible Person services in Ukraine, adapts European PIFs to Ukrainian requirements, coordinates the preparation or review of CPSRs, assesses formulations and product claims, develops compliant labelling, and completes cosmetic product notifications.<\/p>\n<div class=\"wp-block-group is-style-pharma-white-box1\">\n<p><strong>To assess the readiness of your product portfolio, appoint Pharma<\/strong><strong> Navigation<\/strong><strong> as your Responsible Person in Ukraine, or prepare a notification plan, please contact our team:<\/strong><\/p>\n<p><span style=\"color: #0000ff;\"><a style=\"color: #0000ff;\" href=\"mailto:ms@pharma-navigation.com\"><strong>ms@pharma-navigation.com<\/strong><\/a><\/span><\/p>\n<p><span style=\"color: #0000ff;\"><strong><u>+<a style=\"color: #0000ff;\" href=\"tel:380931271630\">38 093 127 16 30<\/a><\/u><\/strong><\/span><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>\u041c\u0430\u0442\u0435\u0440\u0456\u0430\u043b \u043f\u0456\u0434\u0433\u043e\u0442\u043e\u0432\u043b\u0435\u043d\u043e \u0437\u0430 \u0440\u0435\u0437\u0443\u043b\u044c\u0442\u0430\u0442\u0430\u043c\u0438 \u0432\u0435\u0431\u0456\u043d\u0430\u0440\u0443 Cosmetica Italia Servizi \u0449\u043e\u0434\u043e \u043d\u043e\u0432\u043e\u0433\u043e \u0440\u0435\u0433\u0443\u043b\u044e\u0432\u0430\u043d\u043d\u044f \u043a\u043e\u0441\u043c\u0435\u0442\u0438\u0447\u043d\u043e\u0457 \u043f\u0440\u043e\u0434\u0443\u043a\u0446\u0456\u0457 \u0432 \u0423\u043a\u0440\u0430\u0457\u043d\u0456. 30 \u0447\u0435\u0440\u0432\u043d\u044f 2026 \u0440\u043e\u043a\u0443 \u043a\u043e\u043c\u0430\u043d\u0434\u0430 Pharma Navigation \u0434\u043e\u043b\u0443\u0447\u0438\u043b\u0430\u0441\u044f \u0434\u043e \u0432\u0435\u0431\u0456\u043d\u0430\u0440\u0443 Cosmetica Italia Servizi \u00ab\u0415\u043a\u0441\u043f\u043e\u0440\u0442 \u0432 \u0423\u043a\u0440\u0430\u0457\u043d\u0443: \u0447\u0438 \u0433\u043e\u0442\u043e\u0432\u0430 \u0432\u0430\u0448\u0430 \u043a\u043e\u043c\u043f\u0430\u043d\u0456\u044f \u0434\u043e \u043d\u043e\u0432\u0438\u0445 \u043f\u0440\u0430\u0432\u0438\u043b?\u00bb \u0440\u0430\u0437\u043e\u043c \u0456\u0437 \u0431\u043b\u0438\u0437\u044c\u043a\u043e \u0441\u043e\u0442\u043d\u0435\u044e \u0456\u043d\u0448\u0438\u0445 \u0443\u0447\u0430\u0441\u043d\u0438\u043a\u0456\u0432. \u0417\u0430\u0445\u0456\u0434 \u0431\u0443\u0432 \u043e\u0440\u0433\u0430\u043d\u0456\u0437\u043e\u0432\u0430\u043d\u0438\u0439 \u0434\u043b\u044f \u0456\u0442\u0430\u043b\u0456\u0439\u0441\u044c\u043a\u0438\u0445 \u0432\u0438\u0440\u043e\u0431\u043d\u0438\u043a\u0456\u0432, \u0432\u043b\u0430\u0441\u043d\u0438\u043a\u0456\u0432 \u043a\u043e\u0441\u043c\u0435\u0442\u0438\u0447\u043d\u0438\u0445 \u0431\u0440\u0435\u043d\u0434\u0456\u0432, \u0435\u043a\u0441\u043f\u043e\u0440\u0442\u0435\u0440\u0456\u0432 \u0456 [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1060","post","type-post","status-publish","format-standard","hentry","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>\u0423\u043a\u0440\u0430\u0457\u043d\u0430 2026: \u043f\u0440\u0430\u043a\u0442\u0438\u0447\u043d\u0456 \u0432\u0438\u043a\u043b\u0438\u043a\u0438 \u0434\u043b\u044f \u0456\u043c\u043f\u043e\u0440\u0442\u0443 \u043a\u043e\u0441\u043c\u0435\u0442\u0438\u043a\u0438 \u0442\u0430 \u0440\u043e\u043b\u044c \u0412\u0456\u0434\u043f\u043e\u0432\u0456\u0434\u0430\u043b\u044c\u043d\u043e\u0457 \u043e\u0441\u043e\u0431\u0438 - Pharma Navigation<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pharma-navigation.com\/en\/ukrayina-2026-praktychni-vyklyky-dlya-importu-kosmetyky-ta-rol-vidpovidalnoyi-osoby\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u0423\u043a\u0440\u0430\u0457\u043d\u0430 2026: \u043f\u0440\u0430\u043a\u0442\u0438\u0447\u043d\u0456 \u0432\u0438\u043a\u043b\u0438\u043a\u0438 \u0434\u043b\u044f \u0456\u043c\u043f\u043e\u0440\u0442\u0443 \u043a\u043e\u0441\u043c\u0435\u0442\u0438\u043a\u0438 \u0442\u0430 \u0440\u043e\u043b\u044c \u0412\u0456\u0434\u043f\u043e\u0432\u0456\u0434\u0430\u043b\u044c\u043d\u043e\u0457 \u043e\u0441\u043e\u0431\u0438 - Pharma Navigation\" \/>\n<meta property=\"og:description\" content=\"\u041c\u0430\u0442\u0435\u0440\u0456\u0430\u043b \u043f\u0456\u0434\u0433\u043e\u0442\u043e\u0432\u043b\u0435\u043d\u043e \u0437\u0430 \u0440\u0435\u0437\u0443\u043b\u044c\u0442\u0430\u0442\u0430\u043c\u0438 \u0432\u0435\u0431\u0456\u043d\u0430\u0440\u0443 Cosmetica Italia Servizi \u0449\u043e\u0434\u043e \u043d\u043e\u0432\u043e\u0433\u043e \u0440\u0435\u0433\u0443\u043b\u044e\u0432\u0430\u043d\u043d\u044f \u043a\u043e\u0441\u043c\u0435\u0442\u0438\u0447\u043d\u043e\u0457 \u043f\u0440\u043e\u0434\u0443\u043a\u0446\u0456\u0457 \u0432 \u0423\u043a\u0440\u0430\u0457\u043d\u0456. 30 \u0447\u0435\u0440\u0432\u043d\u044f 2026 \u0440\u043e\u043a\u0443 \u043a\u043e\u043c\u0430\u043d\u0434\u0430 Pharma Navigation \u0434\u043e\u043b\u0443\u0447\u0438\u043b\u0430\u0441\u044f \u0434\u043e \u0432\u0435\u0431\u0456\u043d\u0430\u0440\u0443 Cosmetica Italia Servizi \u00ab\u0415\u043a\u0441\u043f\u043e\u0440\u0442 \u0432 \u0423\u043a\u0440\u0430\u0457\u043d\u0443: \u0447\u0438 \u0433\u043e\u0442\u043e\u0432\u0430 \u0432\u0430\u0448\u0430 \u043a\u043e\u043c\u043f\u0430\u043d\u0456\u044f \u0434\u043e \u043d\u043e\u0432\u0438\u0445 \u043f\u0440\u0430\u0432\u0438\u043b?\u00bb \u0440\u0430\u0437\u043e\u043c \u0456\u0437 \u0431\u043b\u0438\u0437\u044c\u043a\u043e \u0441\u043e\u0442\u043d\u0435\u044e \u0456\u043d\u0448\u0438\u0445 \u0443\u0447\u0430\u0441\u043d\u0438\u043a\u0456\u0432. \u0417\u0430\u0445\u0456\u0434 \u0431\u0443\u0432 \u043e\u0440\u0433\u0430\u043d\u0456\u0437\u043e\u0432\u0430\u043d\u0438\u0439 \u0434\u043b\u044f \u0456\u0442\u0430\u043b\u0456\u0439\u0441\u044c\u043a\u0438\u0445 \u0432\u0438\u0440\u043e\u0431\u043d\u0438\u043a\u0456\u0432, \u0432\u043b\u0430\u0441\u043d\u0438\u043a\u0456\u0432 \u043a\u043e\u0441\u043c\u0435\u0442\u0438\u0447\u043d\u0438\u0445 \u0431\u0440\u0435\u043d\u0434\u0456\u0432, \u0435\u043a\u0441\u043f\u043e\u0440\u0442\u0435\u0440\u0456\u0432 \u0456 [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pharma-navigation.com\/en\/ukrayina-2026-praktychni-vyklyky-dlya-importu-kosmetyky-ta-rol-vidpovidalnoyi-osoby\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Navigation\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-17T02:38:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-17T02:49:47+00:00\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"11 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.pharma-navigation.com\\\/ukrayina-2026-praktychni-vyklyky-dlya-importu-kosmetyky-ta-rol-vidpovidalnoyi-osoby\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pharma-navigation.com\\\/ukrayina-2026-praktychni-vyklyky-dlya-importu-kosmetyky-ta-rol-vidpovidalnoyi-osoby\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/www.pharma-navigation.com\\\/#\\\/schema\\\/person\\\/89ae59bb4bd20e61637ef871a7a7b932\"},\"headline\":\"\u0423\u043a\u0440\u0430\u0457\u043d\u0430 2026: \u043f\u0440\u0430\u043a\u0442\u0438\u0447\u043d\u0456 \u0432\u0438\u043a\u043b\u0438\u043a\u0438 \u0434\u043b\u044f \u0456\u043c\u043f\u043e\u0440\u0442\u0443 \u043a\u043e\u0441\u043c\u0435\u0442\u0438\u043a\u0438 \u0442\u0430 \u0440\u043e\u043b\u044c \u0412\u0456\u0434\u043f\u043e\u0432\u0456\u0434\u0430\u043b\u044c\u043d\u043e\u0457 \u043e\u0441\u043e\u0431\u0438\",\"datePublished\":\"2026-07-17T02:38:36+00:00\",\"dateModified\":\"2026-07-17T02:49:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.pharma-navigation.com\\\/ukrayina-2026-praktychni-vyklyky-dlya-importu-kosmetyky-ta-rol-vidpovidalnoyi-osoby\\\/\"},\"wordCount\":1905,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.pharma-navigation.com\\\/#organization\"},\"articleSection\":[\"\u041d\u043e\u0432\u0438\u043d\u0438\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.pharma-navigation.com\\\/ukrayina-2026-praktychni-vyklyky-dlya-importu-kosmetyky-ta-rol-vidpovidalnoyi-osoby\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.pharma-navigation.com\\\/ukrayina-2026-praktychni-vyklyky-dlya-importu-kosmetyky-ta-rol-vidpovidalnoyi-osoby\\\/\",\"url\":\"https:\\\/\\\/www.pharma-navigation.com\\\/ukrayina-2026-praktychni-vyklyky-dlya-importu-kosmetyky-ta-rol-vidpovidalnoyi-osoby\\\/\",\"name\":\"\u0423\u043a\u0440\u0430\u0457\u043d\u0430 2026: \u043f\u0440\u0430\u043a\u0442\u0438\u0447\u043d\u0456 \u0432\u0438\u043a\u043b\u0438\u043a\u0438 \u0434\u043b\u044f \u0456\u043c\u043f\u043e\u0440\u0442\u0443 \u043a\u043e\u0441\u043c\u0435\u0442\u0438\u043a\u0438 \u0442\u0430 \u0440\u043e\u043b\u044c \u0412\u0456\u0434\u043f\u043e\u0432\u0456\u0434\u0430\u043b\u044c\u043d\u043e\u0457 \u043e\u0441\u043e\u0431\u0438 - Pharma Navigation\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pharma-navigation.com\\\/#website\"},\"datePublished\":\"2026-07-17T02:38:36+00:00\",\"dateModified\":\"2026-07-17T02:49:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.pharma-navigation.com\\\/ukrayina-2026-praktychni-vyklyky-dlya-importu-kosmetyky-ta-rol-vidpovidalnoyi-osoby\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.pharma-navigation.com\\\/ukrayina-2026-praktychni-vyklyky-dlya-importu-kosmetyky-ta-rol-vidpovidalnoyi-osoby\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.pharma-navigation.com\\\/ukrayina-2026-praktychni-vyklyky-dlya-importu-kosmetyky-ta-rol-vidpovidalnoyi-osoby\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u0413\u043e\u043b\u043e\u0432\u043d\u0430\",\"item\":\"https:\\\/\\\/www.pharma-navigation.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u0423\u043a\u0440\u0430\u0457\u043d\u0430 2026: \u043f\u0440\u0430\u043a\u0442\u0438\u0447\u043d\u0456 \u0432\u0438\u043a\u043b\u0438\u043a\u0438 \u0434\u043b\u044f \u0456\u043c\u043f\u043e\u0440\u0442\u0443 \u043a\u043e\u0441\u043c\u0435\u0442\u0438\u043a\u0438 \u0442\u0430 \u0440\u043e\u043b\u044c \u0412\u0456\u0434\u043f\u043e\u0432\u0456\u0434\u0430\u043b\u044c\u043d\u043e\u0457 \u043e\u0441\u043e\u0431\u0438\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.pharma-navigation.com\\\/#website\",\"url\":\"https:\\\/\\\/www.pharma-navigation.com\\\/\",\"name\":\"Pharma Navigation\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.pharma-navigation.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.pharma-navigation.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.pharma-navigation.com\\\/#organization\",\"name\":\"Pharma Navigation\",\"url\":\"https:\\\/\\\/www.pharma-navigation.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.pharma-navigation.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.pharma-navigation.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/Blue-Logo-Pharma-Navigation.png\",\"contentUrl\":\"https:\\\/\\\/www.pharma-navigation.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/Blue-Logo-Pharma-Navigation.png\",\"width\":1568,\"height\":505,\"caption\":\"Pharma Navigation\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pharma-navigation.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/t.me\\\/silchenko_regulatory\",\"https:\\\/\\\/wa.me\\\/380931271630?text=HelloIhaveaquestion\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.pharma-navigation.com\\\/#\\\/schema\\\/person\\\/89ae59bb4bd20e61637ef871a7a7b932\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0e993f0e65df48ee51785f6853a1d76934222518f444bacf707cbb1d13ef64b8?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0e993f0e65df48ee51785f6853a1d76934222518f444bacf707cbb1d13ef64b8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0e993f0e65df48ee51785f6853a1d76934222518f444bacf707cbb1d13ef64b8?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"https:\\\/\\\/www.pharma-navigation.com\"],\"url\":\"https:\\\/\\\/www.pharma-navigation.com\\\/en\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u0423\u043a\u0440\u0430\u0457\u043d\u0430 2026: \u043f\u0440\u0430\u043a\u0442\u0438\u0447\u043d\u0456 \u0432\u0438\u043a\u043b\u0438\u043a\u0438 \u0434\u043b\u044f \u0456\u043c\u043f\u043e\u0440\u0442\u0443 \u043a\u043e\u0441\u043c\u0435\u0442\u0438\u043a\u0438 \u0442\u0430 \u0440\u043e\u043b\u044c \u0412\u0456\u0434\u043f\u043e\u0432\u0456\u0434\u0430\u043b\u044c\u043d\u043e\u0457 \u043e\u0441\u043e\u0431\u0438 - Pharma Navigation","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pharma-navigation.com\/en\/ukrayina-2026-praktychni-vyklyky-dlya-importu-kosmetyky-ta-rol-vidpovidalnoyi-osoby\/","og_locale":"en_US","og_type":"article","og_title":"\u0423\u043a\u0440\u0430\u0457\u043d\u0430 2026: \u043f\u0440\u0430\u043a\u0442\u0438\u0447\u043d\u0456 \u0432\u0438\u043a\u043b\u0438\u043a\u0438 \u0434\u043b\u044f \u0456\u043c\u043f\u043e\u0440\u0442\u0443 \u043a\u043e\u0441\u043c\u0435\u0442\u0438\u043a\u0438 \u0442\u0430 \u0440\u043e\u043b\u044c \u0412\u0456\u0434\u043f\u043e\u0432\u0456\u0434\u0430\u043b\u044c\u043d\u043e\u0457 \u043e\u0441\u043e\u0431\u0438 - Pharma Navigation","og_description":"\u041c\u0430\u0442\u0435\u0440\u0456\u0430\u043b \u043f\u0456\u0434\u0433\u043e\u0442\u043e\u0432\u043b\u0435\u043d\u043e \u0437\u0430 \u0440\u0435\u0437\u0443\u043b\u044c\u0442\u0430\u0442\u0430\u043c\u0438 \u0432\u0435\u0431\u0456\u043d\u0430\u0440\u0443 Cosmetica Italia Servizi \u0449\u043e\u0434\u043e \u043d\u043e\u0432\u043e\u0433\u043e \u0440\u0435\u0433\u0443\u043b\u044e\u0432\u0430\u043d\u043d\u044f \u043a\u043e\u0441\u043c\u0435\u0442\u0438\u0447\u043d\u043e\u0457 \u043f\u0440\u043e\u0434\u0443\u043a\u0446\u0456\u0457 \u0432 \u0423\u043a\u0440\u0430\u0457\u043d\u0456. 30 \u0447\u0435\u0440\u0432\u043d\u044f 2026 \u0440\u043e\u043a\u0443 \u043a\u043e\u043c\u0430\u043d\u0434\u0430 Pharma Navigation \u0434\u043e\u043b\u0443\u0447\u0438\u043b\u0430\u0441\u044f \u0434\u043e \u0432\u0435\u0431\u0456\u043d\u0430\u0440\u0443 Cosmetica Italia Servizi \u00ab\u0415\u043a\u0441\u043f\u043e\u0440\u0442 \u0432 \u0423\u043a\u0440\u0430\u0457\u043d\u0443: \u0447\u0438 \u0433\u043e\u0442\u043e\u0432\u0430 \u0432\u0430\u0448\u0430 \u043a\u043e\u043c\u043f\u0430\u043d\u0456\u044f \u0434\u043e \u043d\u043e\u0432\u0438\u0445 \u043f\u0440\u0430\u0432\u0438\u043b?\u00bb \u0440\u0430\u0437\u043e\u043c \u0456\u0437 \u0431\u043b\u0438\u0437\u044c\u043a\u043e \u0441\u043e\u0442\u043d\u0435\u044e \u0456\u043d\u0448\u0438\u0445 \u0443\u0447\u0430\u0441\u043d\u0438\u043a\u0456\u0432. \u0417\u0430\u0445\u0456\u0434 \u0431\u0443\u0432 \u043e\u0440\u0433\u0430\u043d\u0456\u0437\u043e\u0432\u0430\u043d\u0438\u0439 \u0434\u043b\u044f \u0456\u0442\u0430\u043b\u0456\u0439\u0441\u044c\u043a\u0438\u0445 \u0432\u0438\u0440\u043e\u0431\u043d\u0438\u043a\u0456\u0432, \u0432\u043b\u0430\u0441\u043d\u0438\u043a\u0456\u0432 \u043a\u043e\u0441\u043c\u0435\u0442\u0438\u0447\u043d\u0438\u0445 \u0431\u0440\u0435\u043d\u0434\u0456\u0432, \u0435\u043a\u0441\u043f\u043e\u0440\u0442\u0435\u0440\u0456\u0432 \u0456 [&hellip;]","og_url":"https:\/\/www.pharma-navigation.com\/en\/ukrayina-2026-praktychni-vyklyky-dlya-importu-kosmetyky-ta-rol-vidpovidalnoyi-osoby\/","og_site_name":"Pharma Navigation","article_published_time":"2026-07-17T02:38:36+00:00","article_modified_time":"2026-07-17T02:49:47+00:00","author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"11 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.pharma-navigation.com\/ukrayina-2026-praktychni-vyklyky-dlya-importu-kosmetyky-ta-rol-vidpovidalnoyi-osoby\/#article","isPartOf":{"@id":"https:\/\/www.pharma-navigation.com\/ukrayina-2026-praktychni-vyklyky-dlya-importu-kosmetyky-ta-rol-vidpovidalnoyi-osoby\/"},"author":{"name":"admin","@id":"https:\/\/www.pharma-navigation.com\/#\/schema\/person\/89ae59bb4bd20e61637ef871a7a7b932"},"headline":"\u0423\u043a\u0440\u0430\u0457\u043d\u0430 2026: \u043f\u0440\u0430\u043a\u0442\u0438\u0447\u043d\u0456 \u0432\u0438\u043a\u043b\u0438\u043a\u0438 \u0434\u043b\u044f \u0456\u043c\u043f\u043e\u0440\u0442\u0443 \u043a\u043e\u0441\u043c\u0435\u0442\u0438\u043a\u0438 \u0442\u0430 \u0440\u043e\u043b\u044c \u0412\u0456\u0434\u043f\u043e\u0432\u0456\u0434\u0430\u043b\u044c\u043d\u043e\u0457 \u043e\u0441\u043e\u0431\u0438","datePublished":"2026-07-17T02:38:36+00:00","dateModified":"2026-07-17T02:49:47+00:00","mainEntityOfPage":{"@id":"https:\/\/www.pharma-navigation.com\/ukrayina-2026-praktychni-vyklyky-dlya-importu-kosmetyky-ta-rol-vidpovidalnoyi-osoby\/"},"wordCount":1905,"commentCount":0,"publisher":{"@id":"https:\/\/www.pharma-navigation.com\/#organization"},"articleSection":["\u041d\u043e\u0432\u0438\u043d\u0438"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.pharma-navigation.com\/ukrayina-2026-praktychni-vyklyky-dlya-importu-kosmetyky-ta-rol-vidpovidalnoyi-osoby\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.pharma-navigation.com\/ukrayina-2026-praktychni-vyklyky-dlya-importu-kosmetyky-ta-rol-vidpovidalnoyi-osoby\/","url":"https:\/\/www.pharma-navigation.com\/ukrayina-2026-praktychni-vyklyky-dlya-importu-kosmetyky-ta-rol-vidpovidalnoyi-osoby\/","name":"\u0423\u043a\u0440\u0430\u0457\u043d\u0430 2026: \u043f\u0440\u0430\u043a\u0442\u0438\u0447\u043d\u0456 \u0432\u0438\u043a\u043b\u0438\u043a\u0438 \u0434\u043b\u044f \u0456\u043c\u043f\u043e\u0440\u0442\u0443 \u043a\u043e\u0441\u043c\u0435\u0442\u0438\u043a\u0438 \u0442\u0430 \u0440\u043e\u043b\u044c \u0412\u0456\u0434\u043f\u043e\u0432\u0456\u0434\u0430\u043b\u044c\u043d\u043e\u0457 \u043e\u0441\u043e\u0431\u0438 - Pharma Navigation","isPartOf":{"@id":"https:\/\/www.pharma-navigation.com\/#website"},"datePublished":"2026-07-17T02:38:36+00:00","dateModified":"2026-07-17T02:49:47+00:00","breadcrumb":{"@id":"https:\/\/www.pharma-navigation.com\/ukrayina-2026-praktychni-vyklyky-dlya-importu-kosmetyky-ta-rol-vidpovidalnoyi-osoby\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pharma-navigation.com\/ukrayina-2026-praktychni-vyklyky-dlya-importu-kosmetyky-ta-rol-vidpovidalnoyi-osoby\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.pharma-navigation.com\/ukrayina-2026-praktychni-vyklyky-dlya-importu-kosmetyky-ta-rol-vidpovidalnoyi-osoby\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u0413\u043e\u043b\u043e\u0432\u043d\u0430","item":"https:\/\/www.pharma-navigation.com\/"},{"@type":"ListItem","position":2,"name":"\u0423\u043a\u0440\u0430\u0457\u043d\u0430 2026: \u043f\u0440\u0430\u043a\u0442\u0438\u0447\u043d\u0456 \u0432\u0438\u043a\u043b\u0438\u043a\u0438 \u0434\u043b\u044f \u0456\u043c\u043f\u043e\u0440\u0442\u0443 \u043a\u043e\u0441\u043c\u0435\u0442\u0438\u043a\u0438 \u0442\u0430 \u0440\u043e\u043b\u044c \u0412\u0456\u0434\u043f\u043e\u0432\u0456\u0434\u0430\u043b\u044c\u043d\u043e\u0457 \u043e\u0441\u043e\u0431\u0438"}]},{"@type":"WebSite","@id":"https:\/\/www.pharma-navigation.com\/#website","url":"https:\/\/www.pharma-navigation.com\/","name":"Pharma Navigation","description":"","publisher":{"@id":"https:\/\/www.pharma-navigation.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pharma-navigation.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.pharma-navigation.com\/#organization","name":"Pharma Navigation","url":"https:\/\/www.pharma-navigation.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.pharma-navigation.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.pharma-navigation.com\/wp-content\/uploads\/2026\/02\/Blue-Logo-Pharma-Navigation.png","contentUrl":"https:\/\/www.pharma-navigation.com\/wp-content\/uploads\/2026\/02\/Blue-Logo-Pharma-Navigation.png","width":1568,"height":505,"caption":"Pharma Navigation"},"image":{"@id":"https:\/\/www.pharma-navigation.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/t.me\/silchenko_regulatory","https:\/\/wa.me\/380931271630?text=HelloIhaveaquestion"]},{"@type":"Person","@id":"https:\/\/www.pharma-navigation.com\/#\/schema\/person\/89ae59bb4bd20e61637ef871a7a7b932","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/0e993f0e65df48ee51785f6853a1d76934222518f444bacf707cbb1d13ef64b8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0e993f0e65df48ee51785f6853a1d76934222518f444bacf707cbb1d13ef64b8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0e993f0e65df48ee51785f6853a1d76934222518f444bacf707cbb1d13ef64b8?s=96&d=mm&r=g","caption":"admin"},"sameAs":["https:\/\/www.pharma-navigation.com"],"url":"https:\/\/www.pharma-navigation.com\/en\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/www.pharma-navigation.com\/en\/wp-json\/wp\/v2\/posts\/1060","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pharma-navigation.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pharma-navigation.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pharma-navigation.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pharma-navigation.com\/en\/wp-json\/wp\/v2\/comments?post=1060"}],"version-history":[{"count":6,"href":"https:\/\/www.pharma-navigation.com\/en\/wp-json\/wp\/v2\/posts\/1060\/revisions"}],"predecessor-version":[{"id":1069,"href":"https:\/\/www.pharma-navigation.com\/en\/wp-json\/wp\/v2\/posts\/1060\/revisions\/1069"}],"wp:attachment":[{"href":"https:\/\/www.pharma-navigation.com\/en\/wp-json\/wp\/v2\/media?parent=1060"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pharma-navigation.com\/en\/wp-json\/wp\/v2\/categories?post=1060"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pharma-navigation.com\/en\/wp-json\/wp\/v2\/tags?post=1060"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}